Vaccines work by preparing the immune system to recognize a pathogen before the body encounters the actual infection.
COVID-19 vaccines use different technologies, but their overall purpose is to stimulate an immune response against SARS-CoV-2.
For example, mRNA vaccines provide temporary genetic instructions that allow certain cells to produce a harmless version of the viral spike protein.
The immune system recognizes this protein as foreign and begins developing a response.
Other vaccine technologies use different methods to present or deliver viral antigens.
The result is the development of immune components that can recognize the virus.
These include:
-
Antibodies.
-
Memory B cells.
-
T cells.
-
Other components of the immune response.
Why Is Immune Memory Important?
The immune system does not simply respond to an infection and then forget everything.
After vaccination, certain immune cells can remain capable of recognizing the relevant viral components.
If the person later encounters SARS-CoV-2, these memory cells may help produce a faster and more effective response.
This can reduce the likelihood that the infection progresses into severe disease.
However, immunity is not absolute.
The virus can change over time, and protection against infection may decrease as antibody levels decline.
This explains why vaccinated people can still become infected.
The important distinction is that protection against infection and protection against severe disease are not identical.
Vaccines may offer less durable protection against infection while continuing to provide meaningful protection against severe outcomes.
5. Why Vaccinated People Can Still Get COVID-19
One of the most common misunderstandings about COVID-19 vaccination is the belief that vaccinated individuals should never become infected.
That was never a realistic guarantee.
Vaccines are not perfect barriers that prevent every viral particle from entering the body.
Instead, they help prepare the immune system to respond.
Several factors explain why breakthrough infections occur.
Changes in the Virus
SARS-CoV-2 has evolved into different variants.
Mutations can change the structure of viral proteins, including the spike protein targeted by many vaccines.
Some variants have developed the ability to partially evade antibodies generated by previous vaccination or infection.
This can increase the likelihood of breakthrough infections.
Declining Antibody Levels
Antibody levels generally decrease over time after vaccination.
This is a normal feature of the immune response.
However, immune memory may persist even when circulating antibody concentrations decline.
This is one reason protection against severe illness may remain more durable than protection against infection.
Individual Differences
People do not respond identically to vaccines.
Older adults and individuals with weakened immune systems may develop less robust responses.
Certain medical treatments and chronic conditions can also influence immune protection.
For these reasons, vaccination does not provide identical protection to every individual.
A breakthrough infection does not automatically mean that a vaccine has failed. The vaccine may still help reduce the severity of the illness.
6. How Vaccination Can Reduce the Risk of Severe Pneumonia
The central purpose of COVID-19 vaccination has been to reduce the risk of severe disease.
When the immune system recognizes SARS-CoV-2 more effectively, it may control the infection before extensive damage develops.
This can reduce the likelihood of serious complications.
Vaccination can help lower the risk of:
-
Severe respiratory illness.
-
COVID-19 hospitalization.
-
Intensive care admission.
-
Death from COVID-19.
The magnitude of protection depends on several factors.
These include the vaccine product, number and timing of doses, circulating variants, previous infections, age, and immune status.
Vaccination does not guarantee that a person will avoid hospitalization.
However, large population studies and clinical research have demonstrated that COVID-19 vaccines have been important in reducing severe outcomes, particularly during periods when people were at high risk.
Why Does This Matter for the Lungs?
If the immune response controls viral infection before it progresses into extensive lower respiratory disease, the lungs may experience less severe inflammation.
This can reduce the likelihood of widespread pulmonary involvement.
It is important to understand that vaccination does not directly repair damaged lung tissue.
Instead, it helps reduce the risk of the infection developing into the severe disease that can damage that tissue.
7. Why Unvaccinated People May Face a Higher Risk of Severe COVID-19
Before COVID-19 vaccines became available, the global population had little or no vaccine-induced immunity against SARS-CoV-2.
This created conditions in which the virus could cause serious disease across many population groups.
Unvaccinated individuals generally lacked the additional immune preparation provided by vaccination.
During the pandemic, studies found that unvaccinated populations experienced higher rates of severe COVID-19 outcomes than vaccinated populations, particularly during periods when vaccines provided strong protection against hospitalization.
However, vaccination status was never the only factor.
An unvaccinated young and otherwise healthy individual could experience mild illness.
A vaccinated older adult with several chronic conditions could still develop severe disease.
The risk depends on the interaction between multiple factors.
What Happens When the Virus Reaches the Lower Respiratory Tract?
In some patients, SARS-CoV-2 infection can trigger extensive inflammation in the lungs.
Immune cells move into affected tissues to fight the infection.
Although this response is necessary, an excessive or poorly regulated inflammatory reaction can contribute to tissue injury.
Fluid may accumulate within the alveoli.
The walls of the air sacs may become inflamed.
Blood vessels within the lungs may also be affected.
In severe cases, the patient can develop acute respiratory distress syndrome, commonly known as ARDS.
ARDS is a serious condition in which widespread inflammation and lung injury make oxygen exchange extremely difficult.
Patients may require intensive respiratory support.
This is one of the most dangerous complications associated with severe COVID-19.
8. Understanding Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome is a severe form of respiratory failure.
It can occur after different types of serious illness or injury, including severe pneumonia.
In COVID-19 patients, ARDS may develop when extensive lung inflammation damages the alveolar-capillary barrier.
Normally, this barrier allows oxygen and carbon dioxide to move between the air sacs and bloodstream.
When the barrier becomes damaged, fluid can leak into the air spaces.
This interferes with oxygen exchange.
Patients may experience:
-
Severe shortness of breath.
-
Rapid breathing.
-
Low blood oxygen levels.
-
Increased respiratory effort.
-
Confusion in some cases.
-
Organ dysfunction when oxygen delivery becomes inadequate.